Graymark Healthcare, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis

Date: May 15, 2018
Pages: 50
US$ 499.00
Graymark Healthcare, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)

Download PDF Leaflet

Graymark Healthcare, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Graymark Healthcare, Inc. Due Diligence Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Graymark Healthcare, Inc. and its competitors. This provides our Clients with a clear understanding of Graymark Healthcare, Inc. position in the Retail Industry.

  • The report contains detailed information about Graymark Healthcare, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Graymark Healthcare, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Graymark Healthcare, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Graymark Healthcare, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Graymark Healthcare, Inc. business.

About Graymark Healthcare, Inc.

Graymark Healthcare, Inc. operates as a diversified healthcare services company. The company provides diagnosis and care management solution for patients suffering from sleep disorders. It also operates independent retail pharmacy stores. Its subsidiaries include Sleep Management Solutions (SMS) and ApothecaryRx, LLC (ApothecaryRx).


The company conducts business in two operating segments, Sleep Management Solutions and ApothecaryRx.

Sleep Management Solutions Segment

The Sleep Management Solutions segment provides diagnosis, and care management solution for the population of Americans with sleep disorders. The company involves in the provision of diagnostic tests and related studies for sleep disorders through its sleep diagnostic centers; sale of continuous positive airway pressure (CPAP) devices, which are used to treat obstructive sleep apnea (OSA); and ongoing re-supply of components of the CPAP device that need to be replaced.

The company owns and operates sleep testing clinics that diagnose the range of sleep disorders, including OSA, insomnia, narcolepsy, and restless legs syndrome. Its sleep clinics consist of two to eight bed facilities and are overseen by its medical directors. At its sleep clinics, the company administers an overnight polysomnogram, or sleep study, to its patients, which monitors blood oxygen level, heart rate, respiratory function, brain waves, leg movement, and other vital signs through small and painless electrical sensors applied to the patient. Its medical directors provide a diagnosis and report to the referring physician.

In addition to selling CPAP devices to people with OSA, the company offers its patient reorder supply program (PRSP). The PRSP periodically supplies the components of the CPAP device that must be regularly replaced (such as masks, hoses, filters, and other parts) to its patients and other CPAP users. The company provides continuing care to its patients led by its medical directors who are board-certified physicians in sleep medicine and their staff.

ApothecaryRx Segment

The ApothecaryRx segment operates independent retail pharmacy stores selling prescription drugs, over-the-counter drugs, and an assortment of general merchandise. As of December 31, 2009, the company owned and operated 18 retail pharmacies located in Colorado, Illinois, Missouri, Minnesota, and Oklahoma. It primarily engages in the retail sale of prescription drugs, non-prescription drugs, and health related products. It also offers an amount of front-end merchandise, such as cosmetics, gift items, and photographic development services. It offers its products to individual customers, as well as managed-care organizations, insurance companies, employers, and other third-party payors.

The company offers local delivery and assists seniors receiving multiple medications. It also offers durable and home medical equipment, such as walkers and wheelchairs for its customers. Its prescription and non-prescription drug purchases are made through its distributor, Cardinal Healthcare, Inc.


The company purchases its sleep disorder and CPAP devices from Nelcor Puritan Bennet LLC; Fisher & Paykell Appliances Limited; and Philips Respironics, ResMed, Inc.


In 2009, the company acquired Avastra Eastern Sleep Center, Inc., SomniCare, Inc., and SomniTech, Inc.


Pharmacy Competition: The company competes with drugstore chains and mass merchandisers, including Wal-Mart, Walgreens, Target, and CVS.

Sleep Management Solutions: The company competes with durable medical equipment (DME) providers for CPAP devices, such as Apria Healthcare and Lincare Holdings.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. Graymark Healthcare, Inc. Direct Competitors
5.2. Comparison of Graymark Healthcare, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Graymark Healthcare, Inc. and Direct Competitors Stock Charts
5.4. Graymark Healthcare, Inc. Industry Analysis
  5.4.1. Retail Industry Snapshot
  5.4.2. Graymark Healthcare, Inc. Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





Graymark Healthcare, Inc. Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Graymark Healthcare, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Graymark Healthcare, Inc. Major Shareholders
Graymark Healthcare, Inc. History
Graymark Healthcare, Inc. Products
Revenues by Segment
Revenues by Region
Graymark Healthcare, Inc. Offices and Representations
Graymark Healthcare, Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Graymark Healthcare, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Graymark Healthcare, Inc. Capital Market Snapshot
Graymark Healthcare, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Retail Industry Statistics
Graymark Healthcare, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Graymark Healthcare, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1


Graymark Healthcare, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Graymark Healthcare, Inc. 1-year Stock Charts
Graymark Healthcare, Inc. 5-year Stock Charts
Graymark Healthcare, Inc. vs. Main Indexes 1-year Stock Chart
Graymark Healthcare, Inc. vs. Direct Competitors 1-year Stock Charts
Graymark Healthcare, Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top

Ask Your Question

Graymark Healthcare, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: